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In a previous paper, a survey of the relationships among antigens
which were obtained from various normal mouse tissues and which
had comparable solubility properties was presented. This communica-
tion is concerned with an analysis of the immunological relationships of
components similarly obtained, but derived from a variety of trans-
plantable mouse tumors. Several of these tumors possessed the capacity
to survive not only homologous but also heterologous transplantation,
if, in the latter case, the anterior chamber of the eye was utilized as the
transplantation site. Greene3, 14 15 16 has emphasized the fact that this
peculiargrowthproperty is characteristic of embryonic and of malignant
tissues, and that it is not shared by normal adult tissues. Watson36 in-
vestigated the immunological properties of such surviving heterolo-
gously grown tumor transplants and found that their species-specificity
was that of the new host. It would appear, then, that malignant and
embryonic cells possess the ability to initiate, or carry on, an organized
series of synthetic processes upon transplantation into an alien host,
but that the chemical structure of the cellular products synthesized in
their new environment is dependent on that host and differs from the
products synthesized in the original, parent species.
Previously, in the few cases where the species-specificity of a hetero-
transplant was studied, a distinction between the parenchymal elements
of the tumor transplant and the stromal elements was not always
drawn.2' 33 The stromal elements are necessarily supplied by the new
host and therefore are characteristic of that species. However, alterations
in the intracellular components of the parenchymal elements of the
heterologous tumor transplants are of utmost significance. For this
reason theimmunological relationships of thedesoxyribosenucleoprotein
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fractions have been stressed again, for they are derived predominantly
from the nuclei ofthe tumor cells themselves.
It was thought pertinent, however, first to observe the antigenic
relationships which components of homologous tumor transplants bear
to each other as well as to normal mouse tissues, and then to determine
more exactly the nature of their relationship to the components of
heterologously grown tumor transplants.
These experiments extend the study of the reactions of antisera,
which were developed to components of normal mouse tissues, pre-
viously studied, to include their in vitro reactivity with components
derived from mouse tumors. The converse experiments have also been
carried out in which antisera evoked by components obtained from
tumor tissues have been tested with normal tissue antigens as well as
with antigens from homologously and heterologously grown tumor
transplants.
Materialsandmethods
The preparation of tissue fractions and of tumor antisera, as well
as the invitro testing have been carried out as described in the first paper
in this series.27 The mouse tumors employed in this investigation were
carried by subcutaneous transplantation.* They are listed in table 1.
TABLE 1
Number0-iial Of Type of tumor dsg°tibedlby tumor
MT-8 Spontaneous tumor of bronchogenic origin Greene and
Murphy'7
MT-19 Spontaneous ovarian embryoma Jackson and
Brues18
MT-24 Spontaneous anaplastic mammary carcinoma Cloudman5
MT-25 Spontaneous malignant melanoma Algirel
MT-26 Spontaneous malignant melanotic melanoma Cloudman6
L.F. Sarcoma derived fromcultures of normal mouse Earle and
fibroblasts treated with methylcholanthrene Nettleship7
for 111 days
M.F. Sarcomaderived fromcultures of normal mouse Earle and
fibroblasts treated with methylcholanthrene NetdeshipT
for 184 days
Lymphosarcoma Slow-growing lymphoid tumor originally in- Kaplan2'
duced in "A" strain mice by x-ray
These tumor transplants were all supplied by Dr. H. S. N. Greene with the
exception of the lymphosarcoma which was obtained through the courtesy of Dr. Henry
S. Kaplan formerly of the Department of Radiology.
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Experimentalresults
Reactions of antisera which were developed to saline extracts of
normal mouse organs on test with mouse tumor tissue preparations.
Chart I indicates the results of reactions obtained with antisera de-
veloped to saline-soluble components of normal tissues when tested with
three categories of tumor tissue preparations-saline extracts, tumor
residue suspensions, and tumor nucleoprotein suspensions. The re-
actions of these same antisera with normal tissue systems have been
presented in an earlier publication.27 The results there reported were
interpreted as demonstrating quantitative organ-specificity, in that the
maximum titer of each serum was attained with antigens derived from
the original inciting tissue. Here, again, in graphically depicting the
results obtained, the maximum titer is arbitrarily assigned a fixed num-
ber of scale divisions, which is indicated in the column on the far right
of the chart, and all other reactions are recorded in percentage relation
to it.
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In general, the antisera to saline extracts of normal mouse organs
reacted in variable degree with tumor extract antigens. The antibodies
evoked by extracts ofmouse spleen and mouse lung, however, were more
reactive with components of tumor tissues which were soluble in saline,
than were the antibodies evoked by extracts of mouse kidney. The
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antiserum to the extract of mouse spleen reacted with all tumor extract
antigens, but the titers of the reactions varied. With one tumor extract,
MT-8, the reaction was of very high caliber. The antiserum to the
extract of mouse lung reacted, in equally low degree, with six of seven
tumors tested; only MT-24 did not react. On the other hand, except for
one reaction of very low degree with the saline extract of MT-8, kidney
extract antiserum did not react with any other tumor extract.
The reactions that occurred between antisera to extracts of normal
mouse tissues and residue suspensions of mouse tumor tissues were
fewer and of lower caliber than were those that occurred with tumor
extracts. This decreased titer may have been due to the presence of a
relatively small amount of a saline-soluble component which had been
incompletely extracted. It is apparent from Chart I that antisera which
were developed to extracts of mouse spleen and lung were more re-
active with the residues of tumors than was the antiserum to the extract
of mousekidney. It is also apparent from this chart, that there were very
few positive reactions between antisera to saline-soluble components of
normal mouse organs and nucleoproteins from mouse tumors. In fact,
only two reactions were observed in this group. The antiserum to
spleen extract reacted with the nucleoprotein from MT-8, and the
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antiserum to kidney extract reacted with the nucleoprotein from MT-25.
Reactionsofantiserawhich weredevelopedto suspensionsofresidues
of normal mouse organs on test with mouse tumor tissues.
The relationships among components present in the saline-insoluble
residues of normal mouse tissues and those of tumor tissues, as revealed
by the in vitro reactions between antisera which were developed to
residues of normal organs and of tumor tissue preparations, are shown
in Chart II. Reactions between residue antisera and saline extracts of
tumor tissues were anticipated. Incomplete saline extraction of the
tissue-residue suspension which was used as the inciting antigenic mix-
ture might account for in vitro reactions with saline-soluble com-
ponents. It may be seen that antisera to residues of normal mouse
spleen, lung, and liver reacted with five of seven tumor extracts. None
of the antisera in this group reacted with the extracts of MT-24 or
MT-25. The antiserum to the residue of mouse kidney did not react
appreciably with any tumor extract. These reactions are substantially
similar to those obtained with antisera evoked by the saline extracts of
these normal organs on test with the same tumor antigens.
The results of tests between antisera developed to normal organ
residues and tumor tissue preparations indicate that spleen-residue
antiserum had the most widespread reactivity, lung-residue antiserum
also reacted widely with tumor-residue antigens, liver-residue antiserum
reacted with residues of all but two tumors, while kidney-residue
antiserum reacted in very low degree with only one tumor residue,
MT-26. In general, these reactions of normal organ residue antisera with
tumor-residue antigens were of lower caliber than were the analogous
reactions with tumor extracts.
When these antisera to normal organ residues were tested with
nucleoprotein preparations derived from three tumors, only a few
reactions of low titer occurred. The antiserum to the residue of mouse
spleen fixed complement in the presence of the nucleoprotein from
MT-24, the antiserum to mouse lung residue reacted with the nucleo-
proteins from MT-8 and MT-19, mouse liver residue antiserum reacted
with the nucleoprotein from MT-8, while the antiserum to mouse
kidney residue did not react with any tumor nucleoproteins.
Reactions of antisera which were developed to nucleoproteins ob-
tainedfromnormal mouse organs ontestwith tumor tissue preparations.
It was previously shown that when antisera which were incited by
nucleoproteins derived from normal mouse organs were tested with
normal tissue preparations, quantitative organ-specificity was indicated.
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This was particularly apparent in the test system: nucleoprotein
antiserum and saline extract antigen. The results of this experiment
suggested that the nucleoprotein fractions carried the stamp of the
organ from which they had been derived. It seemed pertinent, there-
fore, to determine the range and extent of the immunological reactivity
of antisera elicited by such well-defined normal mouse organ com-
ponents on test with antigens prepared from mouse tumors. Chart III
depicts these results. These data confirm the organ-specific character of
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the nucleoproteins and the selectivity of the reactions of their antisera.
Only minor differences could be observed between the reactions of these
antisera with tumor extracts or with tumor residue suspensions. The
antiserum to the nucleoprotein from spleen reacted somewhat more
prominently with the residue ofMT-8 than it had with the saline extract
ofMT-8. Lung nucleoprotein antiserum did not react with the residue of
N. F., whereas it had reacted with the saline extract of this tumor.
Kidney nucleoprotein antiserum reacted in the same low titer with
residues of six of seven tumors. Liver nucleoprotein antiserum re-
mained generally non-reactive; in fact, it did not even react with the
residue ofMT-26, although ithad reacted with the extract of this tumor.
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Chart III includes the results of in vitro reactions between normal
organ nucleoprotein antisera and nucleoproteins of tumor tissue origin.
The antiserum to lung nucleoprotein reacted to high degree with the
nucleoprotein from MT-8 and to very low degree with the MT-19
nucleoprotein suspension. One reaction of very low titer occurred be-
tween spleen nucleoprotein antiserum and the nucleoprotein from
MT-24. No other positive reactions occurred in this group of experi-
ments. These experiments did not reveal any specific immunological
identitybetween any one nucleoprotein from a normal mouse organ and
one derived from a tumor.
Reactions of antisera developed to the saline extracts of mouse
tumor tissues when tested with normal mouse organ preparations.
To some extent, previous experiments have indicated the relation-
ship which exists between the components of normal tissues and those
of tumor tissues, as determined by the immunological reactivity of
antisera which had been developed to normal tissue components. Many
tumors were found to possess components in common with spleen and
lung, while fewer tumors appeared to possess components related to
those in kidney and liver. It seemed probable that qualitative, as well as
quantitative, distribution of components led to the descriptive reaction
patterns that we had obtained. Since we were frequently unsuccessful
in clarifying the relationships among tissue components by application
of our standard test procedure following absorption with tissue slices,
we felt that further insight into quantitative and qualitative variations
in tissue composition might be gained from experiments in which
antisera were produced to tumor tissue components. The antisera so
produced were studied by means of the same standardized complement-
fixation test and the reaction patterns obtained were compared with
those produced by normal tissue antisera.
Chart IV indicates the results of reactions between antisera evoked
by saline extracts of tumor tissues and preparations of normal mouse
organs. The reactions of four tumor antisera with normal mouse organ
preparations were quite dissimilar. Many reactions seen to occur with
saline extracts were eliminated or decreased in titer on test with the
residue suspension from the same organ, a few remained unaltered or
only slightly altered. The antiserum to the extract of MT-8, which had
reacted slightly with spleen extract, did not react at all with any normal
organ residue suspensions, and reacted only slightly with the residue of
the original inciting tumor. With the exception of a continued marked
reaction with spleen residue, and a new low-titered reaction with liver
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residue, the antiserum to the extract of MT-19 reacted also with residue
suspensions of lung, kidney, and MT-19, but all reacted to a lower
degree than did the corresponding extracts. On the other hand, except
for the loss of the reaction between the antiserum to MT-25 and spleen
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residue, and that between MT-24 and kidney residue, the reactions of
these sera with extracts or residues remained unchanged on in vitro
test. The results of reactions between antisera developed to extracts of
tumors and suspensions of nucleoproteins derived from four normal
organs, revealed that all four tumor extract antisera reacted with the
spleen nucleoprotein preparation, three of these antisera reacted with
lung nucleoprotein, one antiserum reacted with kidney nucleoprotein,
and one reacted with liver nucleoprotein. The reactions of MT-8 and
MT-25 extract antisera with spleen nucleoprotein were of higher titer
than were the reactions with their respective tumor nucleoproteins,
while the antisera to extracts of MT-19 and MT-24, reacted with the
spleen nucleoprotein even when it did not react with the corresponding
tumor nucleoprotein.
As previously observed, antigenic relationships between spleen,
lung, and tumor components were more apparent than were relation-
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ships between kidney or liver and tumor components. From their re-
action patterns, MT-8 and MT-25 behaved like specific organs, or at
least like organs possessing descriptive antigens; MT-19 was only
questionably organ-specific, while MT-24 reacted as if it were a com-
posite of mouse antigens, not uniquely labeled, but containing, in
different concentrations, the various components present also in spleen
and lung.
Reactions of antisera developed to residue suspensions of mouse
tumor tissues when tested with normal mouse organ preparations.
After the bulk of saline-soluble proteins has been removed, it is
more readily possible to observe the behavior of the tissue residues
as inciting antigens, as well as to observe the relationships between
saline-insoluble tumor tissue components and similar components
derived from normal tissues. The results of such reactions are shown in
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Chart V. Despite the
fact that antisera to
extracts of normal
mouse organs be-
haved in a more de-
scriptive or organ-
specific manner on in
vitro test than did
antisera to residues of
normalorgans,on the
wholethereactions of
tumor extractantisera
and tumor residue
antisera appeared
similar.
Antisera to the
residues of MT-8,
MT-25, and MT-26
reacted in somewhat
higher titer with the
extracts of the incit-
ing tumors than with
the extracts of any of
four normal mouse
organs tested. How-
It -a m
m
kM Z _ ._.
19
I;a
Al
-B
a a _ A
* a _ _ mm--YALE JOURNAL OF BIOLOGY AND MEDICINE
ever, antisera to the residues of MT-19 and MT-24 showed reactions of
about the same magnitude with spleen, or lung, or inciting tumor
extract. Three reactions that occurred in low titer when tumor residue
antisera were tested with antigens of normal mouse organs which were
soluble in saline, did not occur when the residues of these same normal
organs which were insoluble in saline were employed: i.e., the antisera
developed to the residues of MT-24 and MT-25 did not react with the
residue of mouse kidney, whereas they had reacted with the extract of
mouse kidney; also the antiserum to the residue of MT-26 did not react
with mouse lung residue, whereas it had reacted with the saline extract
of mouse lung. On the other hand, the antiserum to the residue of
MT-19 reacted more prominently with mouse lung residue than it had
with the saline extract of mouse lung. This antiserum also reacted
with the residue of mouse liver. MT-19 is the only tumor in this group
that evoked antibodies which fixed complement in the presence of a
liver antigen.
The most pronounced reactions in the series of experiments in
which nucleoproteins were employed as test antigens occurred with
the preparation from mouse spleen. Reactions of maximal titer were
obtained when a suspension of nucleoprotein from spleen was titrated
with antisera to the residue of MT-24 and also to the residue of MT-25;
prominent reactions were obtained with antisera to the residues of
MT-8 and MT-19; and a negative test was observed only with the
antiserum to the residue of MT-26. The ability of spleen nucleoprotein
preparations to bind complement in the presence of antisera to extracts
of tumors was pointed out earlier. One antiserum (to MT-24) reacted
with spleen nucleoprotein even when it did not react with the nucleo-
protein prepared from the tumor itself, while another antiserum (to
MT-8) reacted in a somewhat higher titer with spleen nucleoprotein
than it did with the nucleoprotein from the same tumor. Antisera
developed to the residues of two other tumors, MT-19 and MT-25,
reacted as well with spleen nucleoprotein as with nucleoprotein from
the corresponding tumor.
Another interesting reaction in this group was the one that occurred
between the antiserum to the residue of MT-19 and the nucleoprotein
obtained from mouse liver. It will be recalled that this antiserum also
reacted with the residue of mouse liver. This reaction seems particularly
noteworthy in view of the fact that liver antigens appeared to react
only infrequently and possibly with high selectivity.
352IMMUNOCHEMISTRY OF TUMOR TRANSPLANTS
Reactions of antisera developed to nucleoproteins obtained from
mouse tumors MT-8 and MT-19 on test with normal mouse organ
preparations.
It was suggested earlier that the desoxyribosenucleoprotein fraction
might be regarded as a representative material derived specifically from
the nucleus. Further, it was pointed out that antisera developed to
nucleoproteins obtained from different normal mouse organs and from
guinea-pig organs gave rise to distinctive patterns of immunological
reactivity when tested with antigens from other normal organs. Espe-
cially when tested with saline extracts of normal organs, the patterns
obtained suggested that the inciting nucleoproteins were so labeled as
to reflect the tissue from which they had been derived. Furthermore, no
immunological identity could be established between any one nucleo-
protein obtained from a normal organ and one obtained from a tumor
tissue by virtue of the reactions of the antiserum which was developed
to the normal organ nucleoprotein.
Chart VI illustrates the results of reactions between antisera evoked
by nucleoproteins obtained from tumors MT-8 and MT-19 and prepa-
rations from normal mouse organs. The antiserum to the nucleo-
protein from MT-8 reacted with spleen and lung preparations, but did
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not react with preparations from kidney or liver. The reactions of the
antiserum to the nucleoprotein from MT-19 were more widespread.
This antiserum reacted with spleen, lung, and kidney and even reacted
with liver extract. Reactions with spleen nucleoprotein occurred in
fairly high titer with both antisera; lung nucleoprotein reacted in some-
what lower titer with both antisera; kidney nucleoprotein reacted in
low titer only with the antiserum to the nucleoprotein from MT-8;
while no reactions occurred between liver nucleoprotein and either of
these antisera.
Reactions of antisera to mouse tumor tissue preparations on test
with suspensions of mouse brain, uterus, testis, and lymph node.
In previous experiments the antigenic relationships existing among
the components of tumor tissues and the components present in four
normal mouse organs were explored. On the basis of the results of these
reactions, itwaspossible to generalize on the distribution of components
of tumors that were contained also in mouse spleen, lung, kidney, and
liver. However, it was clear from these experiments that judgment con-
cerning the specific or distinctive nature of antigens of tumor cells
which were immunologically differentiable from the components of
only four normal organs would have to be withhield until the antigenic
content of other normal organs was also considered. For this reason, the
experiments were extended to include the reactions of all antisera with
suspensions of mouse brain, uterus, testis, and lymph node. In general,
the patterns confirm our earlier observations. However, the expansion
of the group of normal organ test antigens does bring to light some
new relationships. Prominent among them is the strong reaction of the
testis suspensionwithMT-25 extractantiserum-areactionofmaximum
titer. MT-25, a tumor which had previously appeared to have few or
no intracellular components in common with those of the four normal
mouse organs tested, is now revealed as possessing a component closely
related to one present in testicular tissue. Especially, where a decision
concerning the uniquely distinctive character of a tumor antigen is
required, it would seem important to extend the characterization of the
tumor antigen to include its relationships with the antigens of a
widely diversified number of organs.
In conformity with earlier observations, antisera to residues of
tumorsreactedwidelyand infairly hightiterwithnormal tissue antigens.
Lymphnode suspensions reacted well with antisera to residues ofMT-25
and MT-19 in a manner comparable to that of reactions of spleen
antigens with these antisera.
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Antisera to the nucleoproteins from MT-8 and MT-19 reacted
somewhat with each of these tissues, but the MT-19 antiserum reacted
to its maximum titer with both brain and testes.
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Reactions of antisera to saline extracts of mouse tumor tissues on
test with antigens derived from other mouse tumors.
The results of the reactions of antisera to saline extracts of mouse
tumors when tested with preparations of six other tumors are shown
in Chart VIII. Antisera to the extracts of MT-8, MT-19, and MT-25
reactedmaximallywith their respective tumor extracts, while the MT-24
extract antiserum reacted equally well, and to its maximum extent, with
extracts of six of the seven tumors studied. When tested with residue
suspensions of tumor tissues, many of the reactions were diminished in
titer or eliminated. This was particularly true of the reactions of MT-8
and MT-19 antisera, where the reactions even with the residues of the
inciting tumor were of much lower titer than were the reactions with
the saline extracts of these tumors. The MT-25 extract antiserum was an
exception and reacted equally well with both its saline extract and its
residue. MT-24 extract antiserum reacted with tumor residues in ex-
actly the same way as ithad with their extracts, except for the residues of
N. F. and L. F. with which it did not react.
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There appeared to be a marked decrease in the number of positive
reactions that occurred between tumor extract antisera and tumor
nucleoproteins, as compared with the reactions of these antiserao with
extracts and even residue suspensions from these same tumor tissues.
The antisera developed to extracts of MT-8 and MT-19 did not bind
complement in the presence of any of four tumor nucleoproteins tested.
The MT-25 extract antiserum reacted well with the saline extract and
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residue suspension derived from this tumor, and also reacted with the
nucleoprotein, but it did not react with any other tumor nucleoprotein
preparation. An anomalous reaction of unusually high titer occurred
between theMT-24 antiserum andthenucleoproteinderivedfromMT-8.
This consistent reactivity of the MT-24 antiserum with MT-8 prepara-
tions was observed even though the MT-8 antiserum consistently failed
to react with MT-24 preparations.
Reaction patterns obtained with tumor antisera, like those obtained
with normal tissue antisera, indicate that tumors not only have com-
ponents in common, but some may have antigens that distinguish them,
either because they are present in a given tumor in relatively high
concentration or because they are immunologically distinct.
Reactions of antisera to residue suspensions of mouse tumor tissues
on test with other mouse tumor tissue preparations.
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On the whole, antisera developed to residue suspensions of tumor
tissues reacted widely when tested with other tumor tissue preparations.
Certain similarities between these reactions and those of tumor extract
antisera were observed. From Chart IX it can be seen that the antigens
of tumors MT-8 and MT-25 again appear to be of relatively specific
character; MT-24 appears to be less distinctively constituted; while
MT-19 is difficult to evaluate. The reactions of antisera to residues of
tumor tissues with tumor residue suspensions differ more quantitatively
than qualitatively from reactions with tumor extracts. Certain reactions
may be worthy of note. The antiserum to the residue of MT-8 reacted
with the residue of MT-24, whereas it had not reacted with its extract.
It was pointed out previously that antisera to the extract and to the
residue of MT-24 reacted repeatedly with MT-8 preparations, despite
the fact that MT-8 extract antiserum did not react with any MT-24
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preparation. MT-25, a tumorwhich appeared to possess specific antigens,
appears, from this series of reactions, to possess a component (or com-
ponents) in its residue which is apparently very close to one in the
residue of MT-26, another melanoma. The reciprocal reaction did not
occur; the antiserum to the residue of MT-26 reacted only with the
residue of the original inciting tumor. The general loss of demonstrable
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complement-fixing ability of N.F. and L.F. residues in the presence of
tumor residue antisera was noted here as it was with antisera to extracts
of tumor tissues.
The reactions of antisera which were developed to residues of tumor
tissues appeared quite different from the reactions of antisera to saline
extracts of tumors when tested against nucleoproteins derived from
tumors. The antiserum to the residue of MT-25 continued to show a
high degree of specificity-reacting solely with MT-25 nucleoprotein.
The antiserum to the residue of MT-19 reacted maximally with the
nucleoprotein from this same tumor, and also reacted slightly with the
nucleoprotein preparation from MT-8. The antiserum to the residue of
MT-8 showed afew low-grade reactions with three of four nucleoprotein
antigens, while the antiserum which was evoked by the residue of
MT-24 did not react at all with nucleoproteins of tumor origin. These
reactions of residue antisera contrast somewhat with those obtained
when antisera to tumor extracts were tested with tumor nucleoproteins.
Except in the cases where MT-25 extract antiserum reacted with nucleo-
protein from MT-25, and where MT-24 extract antiserum reacted with
nucleoprotein from MT-8, no other reactions occurred in that group.
The increase in the number of positive reactions that occurred be-
tween nucleoproteins and antisera elaborated to the residues of tumor
tissues, over the reactions of these antigens with antisera elaborated
to saline extracts of tumor tissues, is similar to that observed when
antisera developed to extracts and residues of normal mouse organs
were tested with nucleoprotein antigens. This increased complement-
fixing reactivity of residue antisera with nucleoproteins is probably re-
lated to the fact that the nucleoprotein constitutes a considerable part
of the antigenic composition of the residue suspension but only a small
part of the saline extract.
Reactions of antisera which were developed to the nucleoproteins
from MT-8 and MT-19 on test with tumor tissue preparations.
Chart X shows the variation in immunological reactivity of anti-
sera evoked by nucleoproteins derived from two different tumors and
it also demonstrates selectivity of behavior.
The antiserum developed to the nucleoprotein from MT-19 reacted
equallywell with the extracts and the residues ofboth MT-8 and MT-19,
but reacted only slightly with similar preparations from other tumors.
When tested with nucleoproteins from four different tumors, MT-19
antiserum reacted only with the nucleoprotein derived from the original
inciting tumor. The antiserum developed to the nucleoprotein from
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MT-8 reacted in low degree with all seven tumor extracts. It reacted
maximally with the residue suspensions of MT-8, but did not react with
the residues of tumors MT-19 and N. F., although reactions had been
observed with extracts of these tumors. This serum reacted with the
nucleoprotein from MT-24, but it reacted in somewhat higher titer
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with the nucleoprotein from the tumor MT-8, itself.
Reactions of mouse tumor antisera with guinea-pig normal organs
and with mouse tumors which had been grown in the guinea-pig eye.
When antisera developed to normal mouse organ preparations were
tested with guinea-pig organ preparations the species differences in
fractions of comparable solubility characteristics were very apparent.
The cross-reactions were few, and where they occurred were of very
low caliber. With the present group of mouse tumor antisera, especially
with the extract and residue antisera, there were a few low grade re-
actions with guinea-pig normal organ antigens (Chart XI). However,
the behavior of these antisera to extracts of mouse tumors, when tested
with preparations of MT-8 and of MT-19, which had been grown in
the anterior chamber of the guinea-pig eye, was most interesting. The
antiserum developed to the saline extract of mouse tumor MT-8 did
not react with the extract, the residue suspension, or the nucleoprotein
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of this same tumor after heterologous transplantation. Neither were
reactions observed with guinea-pig transplants of MT-19. The antiserum
to the saline extract of MT-24, which reacted with all MT-8 prepara-
tions, and which also showed a surprisingly high titer with the nucleo-
protein from MT-8, reacted in low titer with the extract and residue
of the heterologously grown tumor, MT-8, whereas it did not react with
the heterologously grown MT-19.
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Antisera to the residues of MT-19 and MT-25 did not react at all
with preparations from the normal organs of the guinea-pig or with
preparations from tumors grown in the guinea-pig. On the other hand,
several positive reactions occurred between the antiserum to the residue
of MT-8 and antigens of guinea-pig origin. This serum reacted with
the extract and the residue of guinea-pig spleen, with the extract of
guinea-pig lung, with the residue of guinea-pig kidney, as well as with
all preparations of the heterologously grown MT-8. It is of interest that
this antiserum to MT-8 did not react with heterologously grown MT-19,
thereby eliminating the suggestion that the reaction with guinea-pig
MT-8 may have been a non-specific reaction with the guinea-pig
stromal elements of that transplant.
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Antisera evoked by nucleoproteins from MT-8 and from MT-19
reacted in low titer with extracts and residues of guinea-pig spleen,
lung, and kidney. Included in the reaction pattern of the antiserum to
the nucleoprotein from MT-19 were reactions with guinea-pig liver
extract and residue, as well as two reactions with nucleoproteins from
guinea-pig spleen and lung. It will be recalled that the antiserum to the
residue of MT-19 did not react in this manner, and also that antisera
to saline-soluble components of both MT-8 and MT-19 reacted only
with mouse organs and not at all with guinea-pig organs. However,
these reactions with preparations of guinea-pig tissues occurred in sub-
stantially reduced titers as compared with the analogous reactions with
mouse organ preparations.
In order to clarify the relationships between the antigens of guinea-
pig-grown tumor transplants and those of normal tissues and of tumor
tissues from the mouse and the guinea-pig, the reactions of prepara-
tions of MT-8 from bothspecies are summarized in table 2. None of the
antisera evoked by saline extracts of normal tissues reacted with either
the extract or the residue of guinea-pig eye-grown MT-8 even when
reactions were observed with the comparable mouse tumor preparation.
Neither did antisera to the saline-soluble components of tumors MT-8,
MT-19, and MT-25 react with these antigens. The antiserum developed
to the extract of MT-24 reacted with the extract and the residue of
guinea-pig grown MT-8 as well as with all test preparations of the
mouse tumor. However, neither the antiserum evoked by the extract
of MT-8 nor that evoked by the extract of MT-24 reacted with the
nucleoprotein obtained from the guinea-pig eye grown transplants.
It can be seen also, that antisera evoked by suspensions of residues
ofnormal mouse tissues did not react with antigens obtained from MT-8
which had been grown in the guinea-pig. Reactions did occur between
the antiserum to the residue of mouse grown MT-8 and all the guinea-
pig MT-8 preparations. But, the reactions with guinea-pig tumor prepa-
rations were always substantially less than were those with the
analogous mouse tumor preparation. Antisera developed to the nucleo-
proteins obtained from normal mouse organs showed no reactions on
test with the extract of guinea-pig MT-8. Neither did antisera developed
to nucleoproteins from MT-19, nor to nucleoprotein from guinea-pig
lung, react with heterologously grown MT-8 preparations. However,
the antiserum evoked by the nucleoprotein from MT-8 reacted with
extracts of both mouse and guinea-pig transplants. The titer of guinea-
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pig tumor reaction was one-tenth that of the mouse tumor reaction.
Similarly, with the residues of MT-8, the mouse tumor residue reacted
to a titer of 400 but the guinea-pig tumor residue reacted to a titer of
10. When tested with MT-8 nucleoprotein suspensions, the titer with
the nucleoprotein from the mouse tumor was 200, while with nucleo-
protein from the guinea-pig tumor the titer was 10.
TABLE 2
MT-8 sus-
Antisera to Max. Extracts Residues N.P. pension
extracts of titer G.P. M. G.P. M. G.P. M. G.P. MT-19
M. Spleen 200 150 70
Lung 50 10
Kidney 50 5 -
MT-8 400 400 - 40 -
MT-19 400 30 200
MT-24 100 10 50 10 50 - 100
MT-25 200 - 50
Lymphosarc. 100 - 5
Antisera to
residues of .t._.
_
M. Spleen 800 400 400
Lung 700 100 300 100
Kidney 400 10
Liver 100 25 50
MT-8 150 40 150 20 100 10 20
MT-19 200 50 100
MT-24 100 10 75 50
MT-25 50 10 10
MT-26 50 10 10
Lymphosarc. 100 50 -_
Antisera to
nucleoprotein
M. Spleen 600 150 10 200 -
Lung 400 75 100
Kidney 50 10 10 10
Liver 50
MT-8 400 20 200 10 400 10 200
MT-19 100 35 50
G.P. Lung 100 ._ _ _-
Discussion
In this communication an attempt has been made to analyze the
antigeniccompositionoftumors inrelation to thecomposition ofnormal
tissues and ofother tumors. It was shown that antisera elicited by prepa-
rations of spleen and lung reacted widely with many tumors, while
antisera evoked by kidney and liver preparations reacted less frequently
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with tumors. The antigenic relationships among the components of
spleen, lung, and tumors were shown even by the reactions of the
nucleoproteins derived from these organs. However, some of the
antigenic components in tumors evoked more narrowly descriptive
antibodies in the rabbit. The immunological patterns obtained with
such antisera enable one to draw distinctions between tumor tissues and
normal tissues.
The reactions of the system in which tumor extract antigens were
tested with tumor extract antisera appeared most specific. Three tumors,
MT-8, MT-19, and MT-25 exhibited reaction patterns which suggested
either quantitatively distinctive distribution of antigenic components
or qualitatively singular components. Whether or not the reactions
of the antisera developed to residues or nucleoproteins from these same
tumors confirm or alter these impressions, the specificity of the reactions
ofsaline-soluble components issignificant, for itsuggests the localization
of a specific tumor component in a fraction of defined solubility prop-
erties. Some tumors did not exhibit such specific antigens.
The immunological properties of tumors like MT-8 raise the
question of the specificity or character of the distinctive antigenic com-
ponent or components which they may possess. The reaction patterns of
antisera evoked by fractions of such a tumor stamp it as decisively as
do the patterns of well-differentiated organs. This tumor certainly pos-
sesses antigens which are closely related to those present in lung and in
spleen, yet the reactions of antisera elicited by the extract and especially
by the nucleoprotein of this tumor suggest the individuality of some
of these components. Absorption experiments have failed to clarify this
relationship. Mann and Welker28 29 and Spinka and Weichselbaum34
report similar experiences with in vitro absorption. Repeated absorption
of antisera to MT-8 with thin slices of spleen removed all reactive
antibodies; repeated absorption of antisera to spleen with thin slices of
the tumor invariably left a small amount of antibody specific for spleen.
The intention of antibody absorption is to arrive at an antiserum of
defined specificity by elimination of cross-reacting antibodies. However,
speculation on the exact nature of the absorption phenomenon raises the
question of just how narrow a range of structurally similar substances
mightbeabsorbed by anygiven antibody which has been induced by any
one of several very closely related antigens. If the components surveyed
in the present experiments possess slight differences in chemical struc-
ture, but are, nevertheless, sufficiently similar as to be absorbed by a
given antibody, one might conceivably exhaust a given antiserum by
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absorption with a number of closely related substances. Such an occur-
rence might not necessarily imply the identity of these antigens but
only a very close similarity. The fact that antisera became extremely
anticomplementary following absorption, though of perhaps minor
theoretical importance, was of major practical importance to us, in
view of the necessity of maintaining conditions constant throughout
these experiments, in an effort to keep the data comparable.
The spleen-lung-MT-8 relationship may be analyzed somewhat
further; the reactions are summarized in tables 3, 4 and 5. The immuno-
TABLE 3
ANTISERA ANTIGENS
Spleen Spleen Spleen
extract residue nucleoprotein
MT-8 extract antiserum 1+ Neg. 2+
MT-8 residue antiserum 3+ 3+ 4+
MT-8 nucleoprotein antiserum 2+ 1+ 2+
MT-8 MT-8 Spleen
extract residue nucleoprotein
Spleen extract antiserum 3+ 1+ (+)#
Spleen residue antiserum 2+ 2+ Neg.
Spleen nucleoprotein antiserum 1+ 1+ Neg.
(+) =a reaction less than 1+.
TABLE 4
ANTISERA ANTIGENS
Lung Lung Lung
extract residue nucleoprotein
MT-8 extract antiserum 1+ Neg. 1+
MT-8 residue antiserum 3+ 3+ Neg.
MT-8 nucleoprotein antiserum 1+ 2+ (+)
MT-8 MT-8 Lung
extract residue nucleoprotein
Lung extract antiserum 2+ Neg. Neg.
Lung residue antiserum 1+ 2+ 1+
Lung nucleoprotein antiserum 1+ 2+ 2+
logical relationships among these three tissues are very close. However,
there is an apparent difference in the in vitro reactions of the nucleo-
proteins derived from each of these tissues. Antisera developed to MT-8
preparations react with nucleoproteins derived from both lung and
spleen, but the reactions with the nucleoproteins from spleen are of
highercaliber. Antiseradeveloped to lungpreparations reactwithnucleo-IMMUNOCHEMISTRY OF TUMOR TRANSPLANTS
TABLE 5
ANTISERA ANTIGENS
Spleen Spleen Spleen
extract residue nucleoprotein
Lung extract antiserum 3+ Neg. 1+
Lung residue antiserum 3+ 2+ 2+
Lung nucleoprotein antiserum 1+ 1+ 4+
Lung Lung Lung
extract residue nucleoprotein
Spleen extract antiserum 3+ 2+ (+)
Spleen residue antiserum 3+ 3+ 1+
Spleen nucleoprotein antiserum 1+ 2+ (+)
proteins from both MT-8 and spleen, but here, also, the reactions with
spleen nucleoprotein are of much higher caliber. In the reciprocal re-
actions, when spleen nucleoprotein is employed as the inciting antigen
and the antiserum so-produced is tested with the nucleoproteins derived
from MT-8 and from lung, reactions observed are either of very low
caliber or are lacking. The nucleoproteins from these three sources
appear to be closely related but certainly do not appear to be identical.
The association between spleen and tumors is historically interesting.
Although Frankl,9' 10 Klemperer24 and Murphy30 31 reported spleen
antagonistic to the tumor cell, this organ has been shown by numerous
other workers to be agood transplantation site. Reports on the cytotoxic
effects of spleen antisera on tumor cells have been presented by
Lumsden,26 by Phelps,32 by Straus,35 and especially by many Russian
investigators since the initiation of the study of anti-reticular cytotoxic
serum by Bogomolets in 1927.3 4 8 However, the results are still in-
conclusive. Extracts of spleen have, in themselves, shown in vivo
cytotoxic effects on mouse sarcoma No. 180.23
More recently Kabat and Furth", reported that submicroscopic
particles obtained from chicken sarcoma were immunologically indis-
tinguishable from particles obtained from normal chicken spleen when
studied bymeans of acomplement-fixation procedure. However, antisera
to the tumor particles were effective in neutralizing the fowl sarcoma
virus whereas antisera to spleen particles were not. Since filtrates of our
tumors could not incite tumor formation this differential test was not
possible in our experiments. But, it is striking that whether or not a
definite causative agent can be detected, the intracellular particles with
whichsuch an agent is associated in the tumorcells is veryclosely related
to similar submicroscopic particles in spleen. The results of Friedewald
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and Kidd"1 also reveal in vitro reactivity between saline extracts of
spleen and antibodies induced in the rabbit by implantation of rabbit
tumors in multiple sites. This seemed especially true of antisera induced
by the Kato sarcoma. The nature, the specificity, and the implications of
tumor antigens have been investigated by Kidd22 23 in great detail. He
believes that these distinctive cell constituents play a significant role
in the proliferative activities of the tumor cell.
Relationships between components of mouse tumors and normal
mouse tissues having been established, it appeared pertinent to attempt
to follow the fate of these tumor components on growth in the guinea-
pig. The components of the heterotransplant which are soluble in saline
and which are probablyofcytoplasmic origin were found to have under-
gone complete alteration. These cytoplasmic components, which possess
organ-specific and species-specific characteristics, appear to be under
the directive influence of the host supporting the growth of the trans-
plant. Morphologically, these tumors are indistinguishable, yet the
chemical structure of the antigens found in the guinea-pig are different
from antigens obtained from similar cellular entities in the original
host. This host influence is further confirmed by transplanting the tumor
from the guinea-pig back into the mouse, where it is found to possess
again the cytoplasmic components characteristic of the mouse. The
suggestion of precursors, or humoral factors, or perhaps local tissue
factors apart from the tumor cell, which modify or direct the synthetic
processes of the tumor cell is difficult to dismiss.
The alteration in the caliber of the reactions of antisera to mouse
tumors with residues and nucleoproteins of these tumors grown in
the guinea-pig also suggests that the nucleus, the trophic center of the
cell, has undergone some chemical alterations. Despite these extra-
cellular influences, there is the persistence of the intrinsic biological
function, or dysfunction of the tumor cell, namely, the replication of
morphologically similar cells. It is highly improbable that the stimulus
can arise from the unaltered fragment of nuclear material per se. It is
moreprobable that this stimulus arises from a factor which we have not
even measured. However, one does not necessarily have to postulate a
positive stimulus. The absence of one or more enzymes might result in
the piling up of an intermediate component which the cell is not
equipped to dispose of efficiently. These intermediate products may
conceivably be responsible for the distinctive reaction patterns of the
tumors.
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Conclusions
1. Characteristic reaction patterns have been obtained for antisera
evoked by antigenic components of mouse tumors. These patterns
reflect the immunological relationships between tumor tissues and
normal tissues.
2. The following generalizations were drawn:
a. All tumors appear to possess intracellular antigenic com-
ponents in common with adult mouse spleen and lung.
b. Some tumors appear to possess a component or components
which may be distinct from those of normal tissues.
c. The nucleoproteins derived from mouse tumors are immuno-
logically distinct from the nucleoproteins obtained from
normal mouse organs.
d. Some tumors, of common cytological origin (e.g., MT-25 and
MT-26, N. F. and L. F.), appear to possess closely related
components. Other tumors, for which no common cytological
origin can be claimed, or which have no apparent morpho-
logical similarity (e.g., MT-8 and lymphosarcoma), also
exhibit close antigenic relationships.
3. When mouse tumors are grown in the anterior chamber of the
guinea-pig eye, their antigenic composition is altered. Components ob-
tained from transplants of mouse tumors grown in the guinea-pig either
no longer react with antisera evoked by components of mouse tumors or
react in considerably reduced titer.
4. Antisera developed to some mouse tumor components, especially
to the residues and nucleoproteins of tumors, react more widely with
components of guinea-pig tissues than do antisera induced by com-
ponents of normal mouse organs.
5. No correlation between the ability of tumors to grow heter-
ologously and any specific antigenic component could be demonstrated.
6. The significance of these observations has been discussed.
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